Applied Total Assets from 2010 to 2026

APLT Stock

USD 0.10 0.00 0.00%

Applied Therapeutics Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 61.4 M in 2026. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2018-12-31

Previous Quarter

37.3 M

Current Value

34.4 M

Quarterly Volatility

46.3 M

Covid

Interest Hikes

Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 4.3 M, Interest Income of 4.3 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 248, Dividend Yield of 0.0 or PTB Ratio of 1.98. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.

Build AI portfolio with Applied Stock

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The evolution of Total Assets for Applied Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Applied Therapeutics compares to historical norms and industry peers.

Latest Applied Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Applied Therapeutics over the last few years. Total assets refers to the total amount of Applied Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Applied Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Applied Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 86.69 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Applied Total Assets Regression Statistics

	Arithmetic Mean	37,073,881
	Geometric Mean	15,310,309
	Coefficient Of Variation	104.84
	Mean Deviation	33,780,109
	Median	20,246,000
	Standard Deviation	38,867,387
	Sample Variance	1510.7T
	Range	101.2M
	R-Value	0.81
	Mean Square Error	552.9T
	R-Squared	0.66
	Significance	0.00008
	Slope	6,238,317
	Total Sum of Squares	24170.8T

Applied Total Assets History

	2026	61.4 M
	2025	99.7 M
	2024	86.7 M
	2023	54.8 M
	2022	38.4 M
	2021	89.9 M
	2020	104.5 M

Other Fundumenentals of Applied Therapeutics

Intangibles To Total Assets

Applied Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Current Deferred Revenue	Net Receivables
Total Assets		0.88	0.91	-0.93	-0.77	0.6	0.9	0.62	0.88	1.0	0.87	0.27	-0.52
Total Stockholder Equity	0.88		0.75	-0.82	-0.57	0.57	0.73	0.24	1.0	0.88	0.96	0.36	-0.28
Net Tangible Assets	0.91	0.75		-0.87	-0.86	0.54	0.99	0.77	0.75	0.91	0.67	0.1	-0.69
Net Debt	-0.93	-0.82	-0.87		0.89	-0.49	-0.9	-0.67	-0.82	-0.93	-0.75	-0.02	0.66
Retained Earnings	-0.77	-0.57	-0.86	0.89		-0.47	-0.92	-0.82	-0.57	-0.77	-0.46	0.33	0.91
Accounts Payable	0.6	0.57	0.54	-0.49	-0.47		0.57	0.32	0.57	0.6	0.53	0.03	-0.26
Capital Surpluse	0.9	0.73	0.99	-0.9	-0.92	0.57		0.8	0.73	0.9	0.64	0.01	-0.75
Total Liab	0.62	0.24	0.77	-0.67	-0.82	0.32	0.8		0.24	0.62	0.16	-0.21	-0.77
Net Invested Capital	0.88	1.0	0.75	-0.82	-0.57	0.57	0.73	0.24		0.88	0.96	0.36	-0.28
Total Current Assets	1.0	0.88	0.91	-0.93	-0.77	0.6	0.9	0.62	0.88		0.87	0.28	-0.52
Net Working Capital	0.87	0.96	0.67	-0.75	-0.46	0.53	0.64	0.16	0.96	0.87		0.48	-0.17
Current Deferred Revenue	0.27	0.36	0.1	-0.02	0.33	0.03	0.01	-0.21	0.36	0.28	0.48		0.6
Net Receivables	-0.52	-0.28	-0.69	0.66	0.91	-0.26	-0.75	-0.77	-0.28	-0.52	-0.17	0.6

Click cells to compare fundamentals

About Applied Therapeutics Financial Statements

Applied Therapeutics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Applied Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Applied Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	99.7 M	61.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC